Zevra Therapeutics, Inc.
ZVRA
$8.21
-$0.12-1.44%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 202.61M | 62.63M | 69.50M | 89.38M | 49.26M |
Total Receivables | 18.27M | 12.62M | 10.51M | 7.79M | 8.95M |
Inventory | 1.11M | 2.56M | 1.97M | -- | -- |
Prepaid Expenses | 4.35M | 3.77M | 4.05M | 2.28M | 2.69M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 226.34M | 81.57M | 86.03M | 99.44M | 60.89M |
|
|||||
Total Current Assets | 226.34M | 81.57M | 86.03M | 99.44M | 60.89M |
Net Property, Plant & Equipment | 2.10M | 2.06M | 1.01M | 1.43M | 1.59M |
Long-term Investments | 4.70M | 4.70M | 4.70M | 4.70M | 4.70M |
Goodwill | 4.70M | 4.70M | 4.70M | 4.70M | 4.70M |
Total Other Intangibles | 7.05M | 67.38M | 68.99M | 70.61M | 66.15M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.00M | 10.91M | 11.38M | 9.27M | 11.07M |
Total Assets | 256.28M | 172.71M | 178.13M | 191.55M | 144.41M |
|
|||||
Total Accounts Payable | 15.84M | 17.82M | 13.08M | 24.46M | 20.45M |
Total Accrued Expenses | 5.60M | 5.17M | 17.37M | 8.55M | 6.77M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 525.00K | 589.00K | 420.00K | 540.00K | 596.00K |
Total Finance Division Other Current Liabilities | 6.87M | 3.40M | 3.20M | 930.00K | 2.63M |
Total Other Current Liabilities | 6.87M | 3.40M | 3.20M | 930.00K | 2.63M |
Total Current Liabilities | 28.83M | 26.98M | 34.07M | 34.48M | 30.45M |
|
|||||
Total Current Liabilities | 28.83M | 26.98M | 34.07M | 34.48M | 30.45M |
Long-Term Debt | 60.69M | 60.09M | 59.50M | 58.90M | 58.33M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1.06M | 1.16M | 372.00K | 483.00K | 544.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 48.46M | 43.46M | 44.52M | 27.91M | 22.61M |
Total Liabilities | 139.05M | 131.69M | 138.46M | 121.78M | 111.93M |
|
|||||
Common Stock & APIC | 564.32M | 560.48M | 555.31M | 550.42M | 479.37M |
Retained Earnings | -433.68M | -508.39M | -505.29M | -469.55M | -436.33M |
Treasury Stock & Other | -13.41M | -11.07M | -10.35M | -11.10M | -10.56M |
Total Common Equity | 117.23M | 41.02M | 39.67M | 69.77M | 32.48M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 117.23M | 41.02M | 39.67M | 69.77M | 32.48M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 117.23M | 41.02M | 39.67M | 69.77M | 32.48M |
|